ABBV Chief Executive

What Robert A. Michael says in public, and what their own SEC filings show they own.

Robert A. Michael

Chairman of the Board & CEO · AbbVie Inc.

Became CEO in 2024, added Chairman role effective July 2025; previously President & COO, CFO; 30+ years at Abbott/AbbVie.

Leadership & board →

What they own

Ownership

Skin in the game

Level 1Steward

Michael owns about 0% of AbbVie Inc., worth $47.2M at the last close.

SEC filings: 23

Stake 178,737 reported shares ≈ 0.0% of shares outstanding — no 13G on file, so an estimate 4/35

Founder No career file yet — the founder axis scores zero until one exists 0/15

Tenure Start date not on file — tenure scores zero until it is 0/10

Track record No career file yet — prior companies score zero until one exists 0/15

Direction No open-market buys or sales in the last year 5/15

Discipline No late Form 4s in 23 filings 10/10

Score = stake band (35) + founder (15) + tenure (10) + track record (15) + 12-month direction (−10…15) + filing discipline (10). Every input links to a filing or to the career file; the bands are ours.

Reported · Forms 3, 4, 5 178,737 Every lot on the person's own filings, as of Feb 27, 2026

Paper trail On time No Form 4 filed outside the two-day window; form 144 flagged below

Reported AbbVie Inc. shares Forms 3, 4 and 5 · as of 2026-02-27

Dots mark the months the activity below moved the line. Hover one for the filing.

How the stake is held

Security	Held via	Shares
Common Stock, $0.01 par value	Direct	178,737
Reported as of 2026-02-27		178,737

Held directly: 100%
Vehicles: None
Last filing: Mar 3, 2026

Activity · last 12 months 2 events folded from 5 filing lines · Every filing on EDGAR ↗

Date	Type	What happened	Shares	Price	Value	Note
Feb 27, 2026	Tax	Shares withheld for tax · Common Stock, $0.01 par value	−36,523	$232.08	$8.5M
Feb 18, 2026	Award	Grant or award across 4 lots · Common Stock, $0.01 par value	+82,439	—	—

Every issuer Robert A. Michael files as an insider of

Company	Role	Reported	Beneficial	% of class
ABBV AbbVie Inc. This page	CHAIRMAN OF THE BOARD AND CEO	178,737 2026-02-27	—	—

Reported is every lot on the person's own Forms 3, 4 and 5 — direct and through trusts. Beneficial is the figure stated on the latest Schedule 13D/G cover page, which can exclude shares the person disclaims and include options exercisable within 60 days, so the two are never added together.

Paper trail

Form 144 Form 144 filed 2024-02-29 announces an intended sale. Filing ↗
Sale 2024-02: sold 68,879 AbbVie Inc. shares for $12,153,957, with the 10b5-1 box unticked (1 filing). Filing ↗
Sale 2022-03: sold 43,105 AbbVie Inc. shares for $6,390,247, with no 10b5-1 plan stated on the filing (1 filing). Filing ↗

23 filings under CIK 0001699914 · captured 2026-09-05 · All filings on EDGAR ↗

On the record with shareholders

Earnings calls

Q2 2026 Jul 31, 2026 Michael's argument was that AbbVie no longer needs the Humira era to be over before the next decade is funded: a quarter that beat its own midpoint by $0.06 on adjusted EPS and grew revenue 10.2%, with Skyrizi, Rinvoq and the whole neuroscience portfolio each above 20%, is what pays for a $10.9bn purchase of Apogee Therapeutics whose assets he framed squarely at "AbbVie's performance in the 20 thirties and beyond". He absorbed the deal's $0.14 of 2026 dilution into guidance rather than carving it out, said the balance sheet still has room for more business development, and on the one question that governs the whole thesis — how long Skyrizi is protected — he put the composition-of-matter expiry at 2033, later US patents into the mid-2030s, and regulatory data protection running to 2031, so no biosimilar filings before the end of this decade. Read the call · 4 quotes →

In their own words

Podcasts, interviews & articles

0 recorded appearances

Who else runs a company like this one

Every CEO we track →

Andrew Dudum Hims & Hers Health, Inc. (HIMS)

David A. Ricks Eli Lilly and Company (LLY)

Joaquin Duato Johnson & Johnson (JNJ)

Stephen J. Hemsley UnitedHealth Group Incorporated (UNH)